Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | — | 229† | 214† | 251† | 247† |
| Net profit | 76 | 16 | 1 | -6 | 15† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Haribabu Bodepudi | Executive Director | June 30, 2026 |
| Rajaram Narayanan | Executive Director | June 30, 2026 |
| Srinivas Vasireddy | Executive Director | June 30, 2026 |
| Kamal Kishore Sharma | Independent Director | June 30, 2026 |
| Milind Shripad Sarwate | Independent Director | June 30, 2026 |
| Revati Parag Kasture | Independent Director | June 30, 2026 |
| Abhiroop Jayanthi | Non-Executive Director | June 30, 2026 |
| Amit Jain | Non-Executive Director | June 30, 2026 |
| Anuj Vishnukumar Poddar | Non-Executive Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
